Genes Tech Group Holdings Company Limited (stock code: 08257) submitted its Monthly Return for Equity Issuer for the period ended 30 November 2025 on 04 December 2025. The report indicates that the company’s authorised share capital remained at HKD 20,000,000, consisting of 2,000,000,000 ordinary shares with a par value of HKD 0.01 each. The issued share capital stood unchanged at 1,000,000,000 ordinary shares, with no treasury shares in circulation.

The announcement also notes a share option scheme adopted on 20 June 2017, under which up to 100,000,000 ordinary shares may be issued. No warrants, convertibles, or agreements that could further alter the share capital were disclosed, and no new shares were issued during the reporting month.